Crescent Biopharma, Inc. (CBIO)

CIK 1253689 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Crescent Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003420
Jul 31, 2026EFFECT9999999995-26-002504
Jul 30, 2026POS AM0001628280-26-050885
Jul 30, 20268-K0001628280-26-050805
Jul 30, 202610-Q0001628280-26-050869
Jul 30, 2026424B30001628280-26-050881
Jul 20, 2026SCHEDULE 13D/A0001104659-26-085114
Jul 20, 202640001104659-26-085113
Jul 15, 20268-K0001628280-26-048347
Jul 15, 2026424B50001628280-26-048344
Jul 14, 2026424B50001628280-26-048144
Jul 14, 20268-K0001628280-26-048151
Jul 10, 2026EFFECT9999999995-26-002258
Jul 1, 2026S-30001628280-26-046544
Jun 23, 202640001628280-26-044890
Jun 23, 202640001628280-26-044892
Jun 23, 202640001628280-26-044885
Jun 23, 202640001628280-26-044887
Jun 23, 202640001628280-26-044884
Jun 23, 202640001628280-26-044893
Jun 23, 202640001628280-26-044886
Jun 22, 2026424B30001628280-26-044718
Jun 22, 202610-Q/A0001628280-26-044713
Jun 3, 202640001628280-26-040575
Jun 3, 202640001628280-26-040577